Identification |
Name: | 1,3-Benzenediol,4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl- |
Synonyms: | 1,3-Benzenediol,4-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, trans-(-)-;Resorcinol, 4-p-mentha-1,8-dien-3-yl-5-pentyl-, trans-(-)- (8CI); AbnormalCannabidiol |
CAS: | 22972-55-0 |
Molecular Formula: | C21H30 O2 |
Molecular Weight: | 314.4617 |
InChI: | InChI=1S/C21H30O2/c1-5-6-7-8-16-12-17(22)13-20(23)21(16)19-11-15(4)9-10-18(19)14(2)3/h11-13,18-19,22-23H,2,5-10H2,1,3-4H3/t18-,19+/m0/s1 |
Molecular Structure: |
|
Properties |
Density: | 1.025 g/cm3 |
Refractive index: | 1.545 |
Water Solubility: | Soluble in DMSO or ethanol |
Solubility: | Soluble in DMSO or ethanol |
Appearance: | Amber oil |
Biological Activity: | Neurobehaviorally inactive cannabinoid that acts as a selective agonist for GPR55 (EC 50 values are 2.5, >30 and >30 μ M at GPR55, CB 1 and CB 2 receptors respectively). Increases phosphorylation of protein kinases in, and migration of, human umbilical vein endothelial cells. |
Safety Data |
|
|